ArticleBritish journal of pharmacology2017

The gap junction modifier ZP1609 decreases cardiomyocyte hypercontracture following ischaemia/reperfusion independent from mitochondrial connexin 43.

Kerstin Boengler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.